Literature DB >> 26176965

Epigenetics in lung fibrosis: from pathobiology to treatment perspective.

Britney A Helling1, Ivana V Yang.   

Abstract

PURPOSE OF REVIEW: Idiopathic pulmonary fibrosis (IPF) is a fatal disease with limited treatment options and extensive gene expression changes identified in the lung parenchyma. Multiple lines of evidence suggest that epigenetic factors contribute to dysregulation of gene expression in IPF lung. Most importantly, risk factors that predispose to IPF - age, sex, cigarette smoke, and genetic variants - all influence epigenetic marks. This review summarizes recent findings of association of DNA methylation and histone modifications with the presence of disease and fibroproliferation. RECENT
FINDINGS: In addition to targeted studies focused on specific gene loci, genome-wide profiles of DNA methylation demonstrate widespread DNA methylation changes in IPF lung tissue and a substantial effect of these methylation changes on gene expression. Genetic loci that have been recently associated with IPF also contain differentially methylated regions, suggesting that genetic and epigenetic factors act in concert to dysregulate gene expression in IPF lung.
SUMMARY: Although we are in very early stages of understanding the role of epigenetics in IPF, the potential for the use of epigenetic marks as biomarkers and therapeutic targets is high and discoveries made in this field will likely bring us closer to better prognosticating and treating this fatal disease.

Entities:  

Mesh:

Year:  2015        PMID: 26176965      PMCID: PMC4592772          DOI: 10.1097/MCP.0000000000000191

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  130 in total

Review 1.  The history of cancer epigenetics.

Authors:  Andrew P Feinberg; Benjamin Tycko
Journal:  Nat Rev Cancer       Date:  2004-02       Impact factor: 60.716

Review 2.  Epithelial stem cell exhaustion in the pathogenesis of idiopathic pulmonary fibrosis.

Authors:  M Chilosi; C Doglioni; B Murer; V Poletti
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2010-07       Impact factor: 0.670

Review 3.  Phenotypic plasticity and the epigenetics of human disease.

Authors:  Andrew P Feinberg
Journal:  Nature       Date:  2007-05-24       Impact factor: 49.962

4.  Cigarette smoking behaviors and time since quitting are associated with differential DNA methylation across the human genome.

Authors:  Emily S Wan; Weiliang Qiu; Andrea Baccarelli; Vincent J Carey; Helene Bacherman; Stephen I Rennard; Alvar Agusti; Wayne Anderson; David A Lomas; Dawn L Demeo
Journal:  Hum Mol Genet       Date:  2012-04-06       Impact factor: 6.150

5.  Architecture of the human regulatory network derived from ENCODE data.

Authors:  Mark B Gerstein; Anshul Kundaje; Manoj Hariharan; Stephen G Landt; Koon-Kiu Yan; Chao Cheng; Xinmeng Jasmine Mu; Ekta Khurana; Joel Rozowsky; Roger Alexander; Renqiang Min; Pedro Alves; Alexej Abyzov; Nick Addleman; Nitin Bhardwaj; Alan P Boyle; Philip Cayting; Alexandra Charos; David Z Chen; Yong Cheng; Declan Clarke; Catharine Eastman; Ghia Euskirchen; Seth Frietze; Yao Fu; Jason Gertz; Fabian Grubert; Arif Harmanci; Preti Jain; Maya Kasowski; Phil Lacroute; Jing Jane Leng; Jin Lian; Hannah Monahan; Henriette O'Geen; Zhengqing Ouyang; E Christopher Partridge; Dorrelyn Patacsil; Florencia Pauli; Debasish Raha; Lucia Ramirez; Timothy E Reddy; Brian Reed; Minyi Shi; Teri Slifer; Jing Wang; Linfeng Wu; Xinqiong Yang; Kevin Y Yip; Gili Zilberman-Schapira; Serafim Batzoglou; Arend Sidow; Peggy J Farnham; Richard M Myers; Sherman M Weissman; Michael Snyder
Journal:  Nature       Date:  2012-09-06       Impact factor: 49.962

6.  Desmoplakin acts as a tumor suppressor by inhibition of the Wnt/β-catenin signaling pathway in human lung cancer.

Authors:  Linlin Yang; Yuan Chen; Tiantian Cui; Thomas Knösel; Qing Zhang; Kai Frederik Albring; Otmar Huber; Iver Petersen
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

7.  Decitabine in the treatment of myelodysplastic syndromes.

Authors:  Hussain I Saba
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

Review 8.  Pre-clinical studies of epigenetic therapies targeting histone modifiers in lung cancer.

Authors:  Kenneth Huffman; Elisabeth D Martinez
Journal:  Front Oncol       Date:  2013-09-09       Impact factor: 6.244

9.  Novel region discovery method for Infinium 450K DNA methylation data reveals changes associated with aging in muscle and neuronal pathways.

Authors:  Mei-Lyn Ong; Joanna Dawn Holbrook
Journal:  Aging Cell       Date:  2013-10-22       Impact factor: 9.304

10.  Integrative analysis of 111 reference human epigenomes.

Authors:  Anshul Kundaje; Wouter Meuleman; Jason Ernst; Misha Bilenky; Angela Yen; Alireza Heravi-Moussavi; Pouya Kheradpour; Zhizhuo Zhang; Jianrong Wang; Michael J Ziller; Viren Amin; John W Whitaker; Matthew D Schultz; Lucas D Ward; Abhishek Sarkar; Gerald Quon; Richard S Sandstrom; Matthew L Eaton; Yi-Chieh Wu; Andreas R Pfenning; Xinchen Wang; Melina Claussnitzer; Yaping Liu; Cristian Coarfa; R Alan Harris; Noam Shoresh; Charles B Epstein; Elizabeta Gjoneska; Danny Leung; Wei Xie; R David Hawkins; Ryan Lister; Chibo Hong; Philippe Gascard; Andrew J Mungall; Richard Moore; Eric Chuah; Angela Tam; Theresa K Canfield; R Scott Hansen; Rajinder Kaul; Peter J Sabo; Mukul S Bansal; Annaick Carles; Jesse R Dixon; Kai-How Farh; Soheil Feizi; Rosa Karlic; Ah-Ram Kim; Ashwinikumar Kulkarni; Daofeng Li; Rebecca Lowdon; GiNell Elliott; Tim R Mercer; Shane J Neph; Vitor Onuchic; Paz Polak; Nisha Rajagopal; Pradipta Ray; Richard C Sallari; Kyle T Siebenthall; Nicholas A Sinnott-Armstrong; Michael Stevens; Robert E Thurman; Jie Wu; Bo Zhang; Xin Zhou; Arthur E Beaudet; Laurie A Boyer; Philip L De Jager; Peggy J Farnham; Susan J Fisher; David Haussler; Steven J M Jones; Wei Li; Marco A Marra; Michael T McManus; Shamil Sunyaev; James A Thomson; Thea D Tlsty; Li-Huei Tsai; Wei Wang; Robert A Waterland; Michael Q Zhang; Lisa H Chadwick; Bradley E Bernstein; Joseph F Costello; Joseph R Ecker; Martin Hirst; Alexander Meissner; Aleksandar Milosavljevic; Bing Ren; John A Stamatoyannopoulos; Ting Wang; Manolis Kellis
Journal:  Nature       Date:  2015-02-19       Impact factor: 69.504

View more
  22 in total

1.  Global DNA hypomethylation has no impact on lung function or serum inflammatory and fibrosis cytokines in asbestos-exposed population.

Authors:  Min Yu; Jianlin Lou; Hailing Xia; Min Zhang; Yixiao Zhang; Junqiang Chen; Xing Zhang; Shibo Ying; Lijin Zhu; Lihong Liu; Guang Jia
Journal:  Int Arch Occup Environ Health       Date:  2017-01-19       Impact factor: 3.015

2.  CBX5/G9a/H3K9me-mediated gene repression is essential to fibroblast activation during lung fibrosis.

Authors:  Giovanni Ligresti; Nunzia Caporarello; Jeffrey A Meridew; Dakota L Jones; Qi Tan; Kyoung Moo Choi; Andrew J Haak; Aja Aravamudhan; Anja C Roden; Y S Prakash; Gwen Lomberk; Raul A Urrutia; Daniel J Tschumperlin
Journal:  JCI Insight       Date:  2019-05-16

3.  TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression.

Authors:  Dakota L Jones; Andrew J Haak; Nunzia Caporarello; Kyoung M Choi; Zhenqing Ye; Huihuang Yan; Xaralabos Varelas; Tamas Ordog; Giovanni Ligresti; Daniel J Tschumperlin
Journal:  J Cell Sci       Date:  2019-10-18       Impact factor: 5.285

Review 4.  The oncogenic landscape of the idiopathic pulmonary fibrosis: a narrative review.

Authors:  Giulia Maria Stella; Vito D'Agnano; Davide Piloni; Laura Saracino; Sara Lettieri; Francesca Mariani; Andrea Lancia; Chandra Bortolotto; Pietro Rinaldi; Francesco Falanga; Cristiano Primiceri; Angelo Guido Corsico; Andrea Bianco
Journal:  Transl Lung Cancer Res       Date:  2022-03

Review 5.  Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives.

Authors:  Scott D Collum; Javier Amione-Guerra; Ana S Cruz-Solbes; Amara DiFrancesco; Adriana M Hernandez; Ankit Hanmandlu; Keith Youker; Ashrith Guha; Harry Karmouty-Quintana
Journal:  Can Respir J       Date:  2017-02-13       Impact factor: 2.409

Review 6.  Idiopathic pulmonary fibrosis and systemic sclerosis: pathogenic mechanisms and therapeutic interventions.

Authors:  Hamid Mattoo; Shiv Pillai
Journal:  Cell Mol Life Sci       Date:  2021-06-18       Impact factor: 9.261

7.  Classifying aging as a disease in the context of ICD-11.

Authors:  Alex Zhavoronkov; Bhupinder Bhullar
Journal:  Front Genet       Date:  2015-11-04       Impact factor: 4.599

Review 8.  Genetics in Idiopathic Pulmonary Fibrosis Pathogenesis, Prognosis, and Treatment.

Authors:  Amarpreet Kaur; Susan K Mathai; David A Schwartz
Journal:  Front Med (Lausanne)       Date:  2017-09-25

Review 9.  Role of pirfenidone in the management of pulmonary fibrosis.

Authors:  Keith C Meyer; Catherine A Decker
Journal:  Ther Clin Risk Manag       Date:  2017-04-03       Impact factor: 2.423

10.  Lung resident mesenchymal cells isolated from patients with the Bronchiolitis Obliterans Syndrome display a deregulated epigenetic profile.

Authors:  Serena Vella; Pier Giulio Conaldi; Emanuela Cova; Federica Meloni; Rosa Liotta; Salvatore Cuzzocrea; Lavinia Martino; Alessandro Bertani; Angelo Luca; Patrizio Vitulo
Journal:  Sci Rep       Date:  2018-07-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.